Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to FOLFOX
Related studies linked through entity extraction aliases.
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
- Status
- RECRUITING
- Phase
- PHASE1
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Trial of Durvalumab (MEDI 4736) in Combination With Extended Neoadjuvant Regimens in Rectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
FOLFOX vs Gemcitabine in Patients With Metastatic Pancreatic Cancer Non-fit to FOLFIRINOX
- Status
- UNKNOWN
- Phase
- PHASE3
COLUMBIA-1: Novel Oncology Therapies in Combination With Chemotherapy and Bevacizumab as First- Line Therapy in MSS-CRC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- Status
- RECRUITING
- Phase
- PHASE1
An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroesophageal Junction (GEJ) Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria
- Status
- UNKNOWN
- Phase
- PHASE3
PETACC-8 miR-31-3p and miR-31-5p Ancillary Study
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy Intensification in Patients With High Lactate Dehydrogenase Values and Soluble Syndecan1 Levels
- Status
- TERMINATED
- Phase
- PHASE2
A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
NAB-PACLITAXEL Plus FOLFOX as Perioperative Chemotherapy in Patients With Operable Oesogastric Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer
- Status
- COMPLETED
- Phase
- PHASE2